Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Siemens healthcare diagnostics has confirmed that the advia centaur br (ca 27.29) assay does not dilute linearly when used with multi-diluent 1 kit lots ending in 2577 and all future lots until further notice. when diluted some samples over-recover the expected neat value by greater than 120%.